| Literature DB >> 34121921 |
Numan Yuksel1, Ahmet Köse1, M Ferdi Fellah1.
Abstract
While the world is in search of a vaccine that can cure COVID-19 disease, favipiravir is the most commonly used antiviral drug in the treatment of patients during the pandemic process. In this study, we investigated the host-guest interaction between the popular supramolecule calix[4]arene derivatives and the favipiravir drug by using the DFT (Density Functional Theory) method. The B3LYP hybrid method and 6-31G (d,p) basis set were utilized to determine the optimized structures of the host and guest molecules and their complexes. The negative adsorption energy (∆E) and adsorption enthalpy (∆H) calculated for the complexes formed between calix[4]arene compounds and favipiravir drug molecule mentioned that adsorption of favipiravir molecule was an exothermic process on calix[4]arene structures. On the other hand, among the calixarene derivatives in the study, Gibbs free energy change (∆G) value for the adsorption was only negative on calix[4]arene4 molecule. The infrared spectroscopy (IR) calculations were performed by examining the C=O, O-H and NH2 vibrational frequencies to see the adsorption behavior in the favipiravir-calix[4]arene complex. After adsorption of the favipiravir molecule, HOMO-LUMO gap values decreased significantly for the structures and therefore electrical conductivity increased proportionally. In addition, sensor response factors, Fermi energy levels and workfunction changes of calix[4]arene derivatives were calculated and examined. Charge transfer between the four calix[4]arene compounds and the favipiravir molecule has occurred after adsorption. This attributes that calix[4]arene derivatives can be used as a well-suited favipiravir sensor (electronic and workfunction) and adsorbent at room temperature. Based on the calculations made to see the solvent effect on the adsorption of favipiravir it was determined that it did not affect the interaction between the drug molecule and the calix[4]arene compound too much and the adsorption energy turned into a slightly less negative value.Entities:
Keywords: Adsorption; Calix[4]arene; DFT; Detection; Favipiravir
Year: 2021 PMID: 34121921 PMCID: PMC8179711 DOI: 10.1007/s10847-021-01087-1
Source DB: PubMed Journal: J Incl Phenom Macrocycl Chem ISSN: 1388-3127 Impact factor: 1.633
Fig. 1Schematic representation for calix[4]arene compounds utilized in this study for the adsorption of favipiravir molecule
Fig. 2Optimized structures of the calix[4]arene derivatives (host molecules) and favipiravir (guest molecule)
Fig. 3Optimized geometries of the host–guest complex between the calix[4]arene derivatives and favipiravir molecule after adsorption
Thermodynamic energy values for the adsorption of favipiravir molecule on calix[4]arene compounds (values are in units of kJ/mol)
| Structure | ΔE | ΔH | ΔG |
|---|---|---|---|
| Calix[4]arene1 | − 23.5 | − 25.9 | 27.3 |
| Calix[4]arene2 | − 23.0 | − 25.5 | 20.4 |
| Calix[4]arene3 | − 16.3 | − 18.8 | 26.8 |
| Calix[4]arene4 | − 40.6 | − 43.0 | − 2.0 |
HOMO and LUMO energies, Fermi level (EF), work function (ɸ) and HOMO–LUMO energy gap (Eg) values (kJ/mol)
| Structures | EHOMO | ELUMO | Eg | ΔEg | %ΔEg | EF | ɸ | %Δɸ |
|---|---|---|---|---|---|---|---|---|
| Calix[4]arene1 | − 541.9 | − 39.2 | 502.8 | − 118.3 | − 23.5 | − 290.6 | 290.6 | 21.6 |
| Complex1 | − 563.0 | − 178.6 | 384.4 | − 370.8 | 370.8 | |||
| Calix[4]arene2 | − 563.7 | − 46.5 | 517.2 | − 108.2 | − 20.9 | − 305.1 | 305.1 | 19.7 |
| Complex2 | − 584.5 | − 175.5 | 409.0 | − 380.0 | 380.0 | |||
| Calix[4]arene3 | − 535.9 | − 36.2 | 499.6 | − 110.4 | − 22.1 | − 286.0 | 286.0 | 22.8 |
| Complex3 | − 565.3 | − 176.0 | 389.3 | − 370.6 | 370.6 | |||
| Calix[4]arene4 | − 526.8 | − 49.6 | 477.2 | − 127.4 | − 26.7 | − 288.2 | 288.2 | 19.9 |
| Complex4 | − 534.6 | − 184.8 | 349.8 | − 359.7 | 359.7 |
The ΔEg indicates the change of Eg after the adsorption process. The %Δɸ indicates the change of ɸ after the adsorption
Chemical hardness, chemical potential, electronegativity and electrophilicity values for the optimized calix[4]arene compounds and the optimized complexes (values are in units of kJ/mol)
| Structure | Chemical hardness (η) | Chemical potential (µ) | Electronegativity (χ) | Electrophilicity (ω) |
|---|---|---|---|---|
| Calix[4]arene1 | 251.4 | − 290.6 | 290.6 | 167.9 |
| Complex1 | 195.2 | − 370.8 | 370.8 | 357.7 |
| Calix[4]arene2 | 258.6 | − 305.1 | 305.1 | 179.9 |
| Complex2 | 204.5 | − 380.0 | 380.0 | 353.0 |
| Calix[4]arene3 | 249.8 | − 286.0 | 286.0 | 163.8 |
| Complex3 | 194.6 | − 370.6 | 370.6 | 352.9 |
| Calix[4]arene4 | 238.6 | − 288.2 | 288.2 | 174.1 |
| Complex4 | 174.9 | − 359.7 | 359.7 | 369.8 |
Fig. 4HOMO and LUMO representations of the optimized structures
Fig. 5Density of states (DOS) schemes for the optimized structures
Fig. 6Electrostatic potential (ESP) distribution maps with projection for the optimized structures
Vibrational frequency values of favipiravir molecule and complexes (values are in units of cm−1)
| Vibrational mode | Favipiravir | Complex 1 | Complex 2 | Complex 3 | Complex 4 |
|---|---|---|---|---|---|
| O–H rocking | 467 | 505 | 502 | 489 | 482 |
| N–H twisting | 608 | 613 | 622 | 617 | 620 |
| C–F stretching | 1302 | 1295 | 1305 | 1302 | 1299 |
| C–O stretching | 1439 | 1432 | 1444 | 1444 | 1440 |
| N–H scissoring | 1562 | 1564 | 1565 | 1564 | 1558 |
| C=O stretching | 1735 | 1731 | 1722 | 1728 | 1734 |
| C–H stretching | 3084 | 3108 | 3077 | 3076 | 3077 |
| N–H symmetric stretching | 3460 | 3458 | 3430 | 3460 | 3455 |
| O–H stretching | 3598 | 3598 | 3560 | 3501 | 3596 |
| N–H asymmetric stretching | 3618 | 3507 | 3508 | 3595 | 2997 |
Fig. 7Infrared spectrums of optimized favipiravir molecule and complex structures